HARPOON THERAPEUTICS INC's ticker is HARP and the CUSIP is 41358P106. A total of 78 filers reported holding HARPOON THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 5.16 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $818,736 | -4.6% | 1,153,148 | 0.0% | 0.00% | – |
| Q1 2023 | $858,173 | +2.5% | 1,153,148 | 0.0% | 0.00% | – |
| Q4 2022 | $836,839 | -25.1% | 1,153,148 | +0.0% | 0.00% | – |
| Q3 2022 | $1,118,000 | -51.5% | 1,152,630 | -4.4% | 0.00% | – |
| Q2 2022 | $2,303,000 | -64.0% | 1,205,751 | -6.4% | 0.00% | – |
| Q1 2022 | $6,402,000 | -32.4% | 1,288,202 | +2.7% | 0.00% | – |
| Q4 2021 | $9,466,000 | -6.8% | 1,253,810 | -2.5% | 0.00% | – |
| Q3 2021 | $10,160,000 | -41.7% | 1,286,182 | +2.4% | 0.00% | – |
| Q2 2021 | $17,419,000 | -29.9% | 1,255,845 | +5.7% | 0.00% | -100.0% |
| Q1 2021 | $24,856,000 | +134.9% | 1,188,126 | +86.5% | 0.00% | – |
| Q4 2020 | $10,583,000 | +10.8% | 637,168 | +13.3% | 0.00% | – |
| Q3 2020 | $9,553,000 | +27.1% | 562,283 | +24.2% | 0.00% | – |
| Q2 2020 | $7,517,000 | +60.8% | 452,760 | +12.2% | 0.00% | – |
| Q1 2020 | $4,674,000 | -19.1% | 403,572 | +3.3% | 0.00% | – |
| Q4 2019 | $5,778,000 | +8.8% | 390,692 | +0.4% | 0.00% | – |
| Q3 2019 | $5,313,000 | +74.4% | 388,951 | +66.0% | 0.00% | – |
| Q2 2019 | $3,047,000 | +289.1% | 234,377 | +183.3% | 0.00% | – |
| Q1 2019 | $783,000 | – | 82,733 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 315,668 | $1,272,142 | 1.63% |
| MPM ASSET MANAGEMENT LLC | 313,136 | $1,261,938 | 0.68% |